Literature DB >> 34988853

Homo sapiens circular RNA 0003602 (Hsa_circ_0003602) accelerates the tumorigenicity of acute myeloid leukemia by modulating miR-502-5p/IGF1R axis.

Qidong Ye1, Nan Li2, Kai Zhou2, Cong Liao2.   

Abstract

Acute myeloid leukemia (AML) has become a worldwide malignant cancer. We intended to investigate the critical roles and mechanism underlying homo sapiens circular RNA 0003602 (hsa_circ_0003602) in AML progression, especially in tumor cell proliferation, migration, invasion, and apoptosis. Real-time PCR was applied to identify the differential expression of hsa_circ_0003602 and miR-502-5p in AML bone marrow tissues and cell lines. In addition, western blot analysis was employed to determine the levels insulin-like growth factor 1 receptor (IGF1R) protein. The biological behaviors were assessed by CCK-8 cell viability assay, flow cytometry assay for apoptosis detection, and Transwell migration and invasion assay. The relationships between target miRNA and downstream mRNA were investigated by bioinformatics, luciferase reporter assay, and biotin-labeled RNA pull-down assay. Hsa_circ_0003602 was upregulated and predicted poor survival in AML. Knockdown of hsa_circ_0003602 in AML cell lines induced the inhibition of proliferation, migration, and invasion and caused apoptosis. Hsa_circ_0003602 sequestered miR-502-5p by functioning as a competitive endogenous RNA (ceRNA), thereby regulating IGF1R expression. Hsa_circ_0003602 acted as a tumor promoter in AML via miR-502-5p/IGF1R axis. Our study provides evidence that hsa_circ_0003602, miR-502-5p, and IGF1R might form a regulatory axis to affect the carcinogenicity of AML cells and provide potential targets for the treatment of AML.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Acute myeloid leukemia; IGF1R; hsa_circ_0003602; miR-502-5p

Mesh:

Substances:

Year:  2022        PMID: 34988853     DOI: 10.1007/s11010-021-04277-0

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  24 in total

Review 1.  Emerging agents and regimens for treatment of relapsed and refractory acute myeloid leukemia.

Authors:  Longzhen Cui; Yan Liu; Yifan Pang; Tingting Qian; Liang Quan; Zhiheng Cheng; Yifeng Dai; Xu Ye; Ying Pang; Jinlong Shi; Xiaoyan Ke; Depei Wu; Lin Fu
Journal:  Cancer Gene Ther       Date:  2019-07-11       Impact factor: 5.987

2.  Impact of insulin-like growth factor 1 and insulin-like growth factor binding proteins on outcomes in acute myeloid leukemia.

Authors:  Reem Karmali; Melissa L Larson; Jamile M Shammo; Sanjib Basu; Kent Christopherson; Jeffrey A Borgia; Parameswaran Venugopal
Journal:  Leuk Lymphoma       Date:  2015-05-14

Review 3.  The research progress of circular RNAs in hematological malignancies.

Authors:  Tingting Ji; Qiuni Chen; Shandong Tao; Yuye Shi; Yue Chen; Li Shen; Chunling Wang; Liang Yu
Journal:  Hematology       Date:  2019-12       Impact factor: 2.269

4.  10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia: a single-centre, phase 2 trial.

Authors:  Courtney D DiNardo; Abhishek Maiti; Caitlin R Rausch; Naveen Pemmaraju; Kiran Naqvi; Naval G Daver; Tapan M Kadia; Gautam Borthakur; Maro Ohanian; Yesid Alvarado; Ghayas C Issa; Guillermo Montalban-Bravo; Nicholas J Short; Musa Yilmaz; Prithviraj Bose; Elias J Jabbour; Koichi Takahashi; Jan A Burger; Guillermo Garcia-Manero; Nitin Jain; Steven M Kornblau; Philip A Thompson; Zeev Estrov; Lucia Masarova; Koji Sasaki; Srdan Verstovsek; Alessandra Ferrajoli; William G Weirda; Sa A Wang; Sergej Konoplev; Zhining Chen; Sherry A Pierce; Jing Ning; Wei Qiao; Farhad Ravandi; Michael Andreeff; John S Welch; Hagop M Kantarjian; Marina Y Konopleva
Journal:  Lancet Haematol       Date:  2020-09-05       Impact factor: 18.959

Review 5.  Circular RNAs: The star molecules in cancer.

Authors:  Jianhong Liu; Dongpei Li; Hui Luo; Xiao Zhu
Journal:  Mol Aspects Med       Date:  2019-10-31

6.  The non-coding RNA landscape of human hematopoiesis and leukemia.

Authors:  Adrian Schwarzer; Stephan Emmrich; Franziska Schmidt; Dominik Beck; Michelle Ng; Christina Reimer; Felix Ferdinand Adams; Sarah Grasedieck; Damian Witte; Sebastian Käbler; Jason W H Wong; Anushi Shah; Yizhou Huang; Razan Jammal; Aliaksandra Maroz; Mojca Jongen-Lavrencic; Axel Schambach; Florian Kuchenbauer; John E Pimanda; Dirk Reinhardt; Dirk Heckl; Jan-Henning Klusmann
Journal:  Nat Commun       Date:  2017-08-09       Impact factor: 14.919

7.  CircRNA SMARCC1 Sponges MiR-140-3p to Regulate Cell Progression in Colorectal Cancer.

Authors:  Miao-Sheng Chen; Cui-Hong Lin; Ling-Yan Huang; Xiao-Ming Qiu
Journal:  Cancer Manag Res       Date:  2020-06-23       Impact factor: 3.989

Review 8.  Recent Progress on Circular RNA Research in Acute Myeloid Leukemia.

Authors:  Muhammad Jamal; Tianbao Song; Bei Chen; Muhammad Faisal; Zixi Hong; Tian Xie; Yingjie Wu; Shan Pan; Qian Yin; Liang Shao; Qiuping Zhang
Journal:  Front Oncol       Date:  2019-11-06       Impact factor: 6.244

Review 9.  The role of allogeneic stem cell transplantation in the management of acute myeloid leukaemia: a triumph of hope and experience.

Authors:  Justin Loke; Ram Malladi; Paul Moss; Charles Craddock
Journal:  Br J Haematol       Date:  2019-12-10       Impact factor: 6.998

View more
  2 in total

Review 1.  Circular RNAs Activity in the Leukemic Bone Marrow Microenvironment.

Authors:  Francesca Liccardo; Alessia Iaiza; Martyna Śniegocka; Silvia Masciarelli; Francesco Fazi
Journal:  Noncoding RNA       Date:  2022-07-01

2.  Research Progress of B-Cell Lymphoma/Leukemia-2 Inhibitor Combined with Azacytidine in the Targeted Therapy of Acute Myeloid Leukemia.

Authors:  Yanyu Wang; Dan Huang; Lejia Liu; Aixin Wang; Yuan Gao; Huan Lin
Journal:  Comput Math Methods Med       Date:  2022-10-08       Impact factor: 2.809

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.